Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132199) titled 'A multicenter real-world study on the efficacy, safety, and optimal dosage of deuterobenzazine tablets for the treatment of tardive dyskinesia' on Sept. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: CHAOHU HOSPITAL OF ANHUI MEDICAL UNIVERSITY
Condition:
Tardive Dyskinesia
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: Deutetrabenazine Treatment Group:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341448
Published by HT Digital Content Services with permiss...